Combination of a mean transit time measurement with an acetazolamide test increases predictive power to identify elevated oxygen extraction fraction in occlusive carotid artery diseases

Journal of Nuclear Medicine

Volumn 49, Issue 12, 2008, Pages 1922-1927

  Hokari, Masaaki ^a   Kuroda, Satoshi ^a   Shiga, Tohru ^a   Nakayama, Naoki ^a   Tamaki, Nagara ^a   Iwasaki, Yoshinobu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acetazolamide; Carotid artery; Cerebral ischemia; Mean transit time; Oxygen extraction fraction

Indexed keywords

ACETAZOLAMIDE; OXYGEN 15;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MIDDLE CEREBRAL ARTERY; OXYGEN EXTRACTION FRACTION; OXYGEN SATURATION; POSITRON EMISSION TOMOGRAPHY; PREDICTION AND FORECASTING; PREDICTIVE VALIDITY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STROKE; TRANSIENT ISCHEMIC ATTACK;

ACETAZOLAMIDE; ADULT; AGED; ALGORITHMS; CAROTID STENOSIS; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OXYGEN RADIOISOTOPES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 57149097690     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.054379     Document Type: Article

References (21)

1. 15O positron emission tomography. Stroke. 1981;12:454-459.
2. Powers WJ, Grubb RL Jr, Raichle ME. Physiological responses to focal cerebral ischemia in humans. Ann Neurol. 1984;16:546-552.
3. Derdeyn CP, Videen TO, Fritsch SM, Carpenter DA, Grubb RL Jr, Powers WJ. Compensatory mechanisms for chronic cerebral hypoperfusion in patients with carotid occlusion. Stroke. 1999;30:1019-1024.
4. Grubb RL Jr, Derdeyn CP, Fritsch SM, et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA. 1998;280:1055-1060.
5. Yamauchi H, Fukuyama H, Nagahama Y, et al. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases. J Nucl Med. 1999;40:1992-1998.
6. Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke. 2001;32:2110-2116.
7. Ogasawara K, Ogawa A, Yoshimoto T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke. 2002;33:1857-1862.
8. Kuroda S, Shiga T, Houkin K, et al. Cerebral oxygen metabolism and neuronal integrity in patients with impaired vasoreactivity attributable to occlusive carotid artery disease. Stroke. 2006;37:393-398.
9. Nemoto EM, Yonas H, Kuwabara H, et al. Identification of hemodynamic compromise by cerebrovascular reserve and oxygen extraction fraction in occlusive vascular disease. J Cereb Blood Flow Metab. 2004;24:1081-1089.
10. Kuroda S, Kamiyama H, Abe H, Houkin K, Isobe M, Mitsumori K. Acetazolamide test in detecting reduced cerebral perfusion reserve and predicting long-term prognosis in patients with internal carotid artery occlusion. Neurosurgery. 1993;32:912-918.
11. Hokari M, Kuroda S, Shiga T, Nakayama N, Tamaki N, Iwasaki Y. Impact of oxygen extraction fraction on long-term prognosis in patients with reduced blood flow and vasoreactivity because of occlusive carotid artery disease. Surg Neurol. May 29, 2008 [Epub ahead of print].
12. Kuroda S, Shiga T, Ishikawa T, et al. Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases. J Nucl Med. 2004;45:943-949.
13. 123I-iodoamphetamine single-photon emission computed tomography in patients with carotid occlusive diseases. Stroke. 2002;33:2217-2223.
14. Yamauchi H, Okazawa H, Kishibe Y, Sugimoto K, Takahashi M. Oxygen extraction fraction and acetazolamide reactivity in symptomatic carotid artery disease. J Neurol Neurosurg Psychiatry. 2004;75:33-37.
15. Gibbs JM, Wise RJ, Leenders KL, Jones T. Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet. 1984;1:310-314.
16. Yata K, Suzuki A, Hatazawa J, et al. Relationship between cerebral circulatory reserve and oxygen extraction fraction in patients with major cerebral artery occlusive disease: a positron emission tomography study. Stroke. 2006;37:534-536.
17. 99mTc-RBC SPECT [in Japanese]. No Shinkei Geka. 1990;18:259-266.
18. Okazawa H, Yamauchi H, Sugimoto K, Takahashi M. Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease. J Nucl Med. 2003;44:1371-1378.
19. Derdeyn CP, Videen TO, Yundt KD, et al. Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. Brain. 2002;125:595-607.
20. Schumann P, Touzani O, Young AR, Morello R, Baron JC, MacKenzie ET. Evaluation of the ratio of cerebral blood flow to cerebral blood volume as an index of local cerebral perfusion pressure. Brain. 1998;121:1369-1379.
21. Sakai F, Igarashi H, Suzuki S, Tazaki Y. Cerebral blood flow and cerebral hematocrit in patients with cerebral ischemia measured by single-photon emission computed tomography. Acta Neurol Scand Suppl. 1989;127:9-13.